Trial Details

UNKNOWN
Basic Information
Clinical ID c1245
Identifier NCT01494857
Trial Title Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Adalimumab
Participant Information
Sponsor Clalit Health Services
City Herzlyia
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-01-12
Primary Completion Date 2025-12-13
Completion Date 2025-12-13